Exploration of the Optimal Desmopressin Treatment in Children With Monosymptomatic Nocturnal Enuresis: Evidence From a Chinese Cohort

• Main Authors: Jiaojiao Liu (Author), Jiajia Ni (Author), Qianfan Miao (Author), Chunyan Wang (Author), Fang Lin (Author), Qi Cao (Author), Wei Guo (Author), Xue Yang (Author), Xiaolu Ji (Author), Yihui Zhai (Author), Yunli Bi (Author), Qian Shen (Author), Hong Xu (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objectives: Nocturnal enuresis (NE) is a common pediatric condition, and desmopressin (dDAVP) is a first-line therapy for NE. The standard initial dosage of dDAVP is 0. 2 mg/day, and most guidelines recommend that the dose should be increased at 0.2 mg increments until dryness is achieved or to the...